Announcement on Approval of Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Party Transaction Matters by China Securities Regulatory Commission

Maple Medical Co., Ltd.·July 24, 2026·3 pages

✨ AI Summary

Guangzhou Medprin Biomedical Technology Co., Ltd. announces that the China Securities Regulatory Commission has approved its plan to issue shares and pay cash to acquire assets and raise supporting funds. This approval covers the issuance of shares to multiple parties for the acquisition of 100% equity in Guangzhou Yijie Medical Technology Co., Ltd. and the fundraising of up to RMB 133,576,400.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Guangzhou Medprin Biomedical Technology Co., Ltd.

Announcement on Approval of Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Party Transaction Matters

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and have no false records, misleading statements, or significant omissions.

Guangzhou Medprin Biomedical Technology Co., Ltd. (hereinafter referred to as the "Listed Company" or the "Company") intends to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. (hereinafter referred to as the "Target Company" or "Yijie Medical") held by Guangzhou Zexin Medical Technology Co., Ltd., Guangzhou Yichuangxiang Investment Partnership (Limited Partnership), and 8 other counterparties by issuing shares and paying cash, and to raise supporting funds (hereinafter referred to as the "Transaction").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.